InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Chen Hongming. Officer active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 4 disclosures have been published. Split: 0 buy · 3 sells. Total volume traded: €52k. Activity tracked since 28 June 2021. The latest transaction was filed on 26 October 2021 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chen Hongming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
46,839,443 股ShareXHKGHKEX:DA20260615E00269
9,449 股@ US$1.8028.0% 占其流量Common StockSEC:0001415889-21-005014:0
5,548 股@ US$5.5649.4% 占其流量Common StockSEC:0001415889-21-003271:0
2,452 股@ US$5.7722.6% 占其流量Common StockSEC:0001415889-21-003261:0
4 条申报中的 4 条
About Chen Hongming
Chen Hongming is a director at Kala Pharmaceuticals, Inc.
